Literature DB >> 8018386

Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand.

H Ichimura1, S C Kliks, S Visrutaratna, C Y Ou, M L Kalish, J A Levy.   

Abstract

Twenty-three HIV-1 isolates were recovered from PBMCs from 26 HIV-1-seropositive individuals in northern Thailand. The viruses grew readily in human PBMCs but only 7 of 17 (41.2%) and 5 of 17 (29.4%) replicated and only at a low level in primary macrophages and in established T cell lines, respectively. By immunoblot assays, sera from Thai subjects were strongly reactive with gp120 from a Thailand isolate, moderately reactive with a Rwandan isolate, and weakly reactive with a North American strain. These three viruses represent, respectively, examples of subtypes E, A, and B as classified by the sequences of the envelope region. Serological assays indicated that broadly reactive rather than type-specific neutralizing activity was detected among these northern Thai sera. The majority of the sera (approximately 75%) neutralized a representative Thailand isolate and the Rwanda isolate but only 55% neutralized the North American strain. However, the difference was not statistically significant. The genetic analyses indicated that nearly all the Thai isolates were highly homogeneous and distinct from the North American/European consensus sequence (subtype B); they belong to subtype E. This is the first report providing biological, serological, and genetic characterization of HIV-1 strains from Thailand. The findings suggest these viruses were recently introduced into the country and that serological evaluation of viral strains needs to be considered along with genetic subtyping when developing an HIV-1 vaccine.

Entities:  

Keywords:  Asia; Data Analysis; Developing Countries; Diseases; Examinations And Diagnoses; Hiv; Hiv Infections; Hiv Serodiagnosis; Laboratory Examinations And Diagnoses; Research Report; Southeastern Asia; Thailand; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 8018386     DOI: 10.1089/aid.1994.10.263

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.

Authors:  F Voulgaropoulou; B Tan; M Soares; B Hahn; L Ratner
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.

Authors:  K Sherefa; M Sällberg; B Johansson; M Salminen; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

5.  A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure.

Authors:  T Shiino; K Kato; N Kodaka; T Miyakuni; Y Takebe; H Sato
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.

Authors:  H Sato; T Shiino; N Kodaka; K Taniguchi; Y Tomita; K Kato; T Miyakuni; Y Takebe
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope.

Authors:  T C VanCott; J R Mascola; L D Loomis-Price; F Sinangil; N Zitomersky; J McNeil; M L Robb; D L Birx; S Barnett
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

Authors:  J P Anderson; A G Rodrigo; G H Learn; A Madan; C Delahunty; M Coon; M Girard; S Osmanov; L Hood; J I Mullins
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

Authors:  J P Moore; Y Cao; J Leu; L Qin; B Korber; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.

Authors:  T M Richardson; B L Stryjewski; C C Broder; J A Hoxie; J R Mascola; P L Earl; R W Doms
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.